News - Financial

Filter

Current filters:

Financial

Popular Filters

60 to 84 of 1447 results

Bayer results boosted by strong pharma performance

Bayer results boosted by strong pharma performance

28-02-2014

Germany’s Bayer this morning posted financial results for 2013, showing that group sales for the year…

BayerFinancialPharmaceutical

Valeant Pharma returns to profit, boosted by B&L acquisition

27-02-2014

Canadian drugmaker Valeant Pharmaceuticals International has announces fourth quarter financial results…

Bausch & LombFinancialGenericsValeant Pharmaceuticals

Mylan 4th-qtr 2013 adjusted diluted EPS increases 20%, beating expectations

27-02-2014

US generics major Mylan reported financial results for the fourth-quarter and full year 2013, showing…

FinancialGenericsMylan Laboratories

Record-breaking recoveries from US DoJ/HHS joint efforts to combat health care fraud

27-02-2014

US Attorney General Eric Holder and Health and Human Services Secretary Kathleen Sebelius have released…

FinancialHealthcareLegalNorth AmericaPharmaceuticalUSA

Australian patients benefit from PBS changes; cancer research

27-02-2014

New medicines for glaucoma, diabetes and advanced soft tissue sarcoma have been approved for listing…

Asia-PacificAustraliaDiabetesFinancialHealthcareKombiglyzeOncologyPharmaceuticalResearchTrajentaVotrient

Merck returns rights to ridaforolimus to Ariad, whose 4th-qtr net loss widens

Merck returns rights to ridaforolimus to Ariad, whose 4th-qtr net loss widens

26-02-2014

US pharma giant Merck & Co has told partner Ariad Pharmaceutical that it is terminating its license agreement…

Ariad PharmaceuticalsFinancialLicensingMerck & CoOncologyPharmaceuticalridaforolimus

China set to overtake USA bioscience market

26-02-2014

Bioscience research in China is set to overtake the USA within the next five to ten years, data from…

Asia-PacificBiotechnologyChinaFinancialJapanResearchUSA

Core products boost UCB 2013 sales, but profits disappoint

26-02-2014

Belgium’s largest drugmaker UCB this morning reported financial results for 2013, with gross profit…

FinancialPharmaceuticalUCB

Vivus earnings beat expectations

25-02-2014

USA-based Vivus has reported fourth-quarter and full-year 2013 financial results that beat analysts’…

FinancialPharmaceuticalVivus

Endo agrees $193 million settlement with US Justice Dept over Lidoderm

23-02-2014

US drugmaker Endo Health Solutions and its subsidiary Endo Pharmaceuticals have agreed to pay $192.7…

Endo Health SolutionsFinancialLegalLidodermMarkets & MarketingNeurologicalPharmaceutical

Setting the record straight: Australia’s PBS expenditure is in decline

21-02-2014

Comments made this week by Australia’s federal Health Minister, Peter Dutton MP, about expenditure…

Asia-PacificAustraliaFinancialGenericsHealthcarePharmaceutical

Actavis net revenue rise 59% beats forecasts; non-GAAP EPS rises 99%

Actavis net revenue rise 59% beats forecasts; non-GAAP EPS rises 99%

20-02-2014

Acquisitive Ireland-headquartered generics major Actavis says that net revenue leapt 59% to $2.779 billion…

ActavisFinancialGenerics

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

Vitae Pharma earns $14 million milestone from Boehringer Ingelheim in Alzheimer's collaboration

20-02-2014

US clinical-stage biotech firm Vitae Pharmaceuticals says it has earned a $14 million milestone payment…

BiotechnologyBoehringer IngelheimFinancialNeurologicalResearchVitae Pharmaceuticals

Funding restrictions for rituximab and eltrombopag widened in New Zealand

Funding restrictions for rituximab and eltrombopag widened in New Zealand

20-02-2014

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of proposals to widen…

Asia-PacificeltrombopagFinancialGlaxoSmithKlineHealthcareImmunologicalsNew ZealandPharmaceuticalrituximabRoche

Fitch affirms Actavis at “BBB-” on Forest Labs acquisition; outlook Stable

20-02-2014

Fitch Ratings has affirmed the ratings of generic drugs major Actavis and subsidiaries at “BBB-”…

ActavisFinancialForest LaboratoriesMergers & AcquisitionsPharmaceutical

Lundbeck raises $1.2 million by increasing share capital

Lundbeck raises $1.2 million by increasing share capital

19-02-2014

Danish CNS drug specialist Lundbeck will raise 6,753,283 Danish kroner ($1,242,714) by increasing its…

DenmarkFinancialLundbeckPharmaceutical

Mologen raises cash to fund Phase III trial of colorectal cancer drug

19-02-2014

German drug development company Mologen has raised 15.7 million euros ($21.6 million) in order to fund…

FinancialGermanyOncologyPharmaceuticalResearch

Report: IPOs and government support can boost the Australian life sciences industry

Report: IPOs and government support can boost the Australian life sciences industry

18-02-2014

Despite a relatively flat December quarter for the PricewaterhouseCoopers Life Sciences Index, it was…

AustraliaBiotechnologyCSL LimitedFinancialMarkets & MarketingPharmaceutical

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

New NPS MedicineWise annual evaluation report indicates Australian PBS savings

18-02-2014

The 16th NPS MedicineWise Annual Evaluation Report provides a snapshot of the organization’s progress…

Asia-PacificAustraliaFinancialHealthcarePharmaceutical

Servier Canada collaborates in two research projects

Servier Canada collaborates in two research projects

17-02-2014

Two major projects in clinical research conducted by Canada’s Montreal Heart Institute (MHI) and the…

CanadaCardio-vascularFinancialNorth AmericaPharmaceuticalResearchServier

Co-payments and co-insurance fees for drugs rise 34% under USA’s Affordable Care Act

Co-payments and co-insurance fees for drugs rise 34% under USA’s Affordable Care Act

14-02-2014

An examination of new health plans from 46 states in the USA revealed that co-payments and co-insurance…

FinancialHealthcareNorth AmericaPharmaceuticalUSA

Another milestone for GenVec in hearing and balance collaboration

13-02-2014

US biotech firm GenVec says it has achieved the third milestone in its collaboration with Swiss drug…

BiotechnologyCGF166FinancialGenVecLicensingNeurologicalNovartis

Shire posts top year-end results and expects earnings to rise again in 2014

Shire posts top year-end results and expects earnings to rise again in 2014

13-02-2014

Ireland-headquartered drugmaker Shire has recorded a rise in sales and earnings to deliver strong full-year…

DermagraftFinancialFirazyrIntunivLialdaMezavantNorthern EuropePharmaceuticalShireViroPharmaVprivVyvanse

Australia’s CSL posts solid half-year results

Australia’s CSL posts solid half-year results

13-02-2014

Australian blood products and vaccine maker CSL reported a 3% rise in net profit to $646 million (all…

CSL LimitedFinancialHematologyPharmaceuticalVaccines

60 to 84 of 1447 results

Back to top